High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 26, Issue 2, 2000, Pages 147-152

  Lee, K H ^a   Lee, J H ^a   Kim, S ^a   Lee, J S ^a   Kim, S H ^a   Kim, W K ^a  

^a Asan Medical Center   (South Korea)

Author keywords

Acute leukemia; Allogeneic BMT; Extramedullary relapse; GVL effect

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA; METHOTREXATE; PHENYTOIN;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RELAPSE;

EID: 0033916072     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702488     Document Type: Article

References (29)

1. Giralt SA, Champlin RE. Leukemia relapse after allogeneic bone marrow transplantation: a review. Blood 1994; 84: 3603-3612.
2. Barrett AJ, Horowitz MM, Gale RP et al. Marrow transplantation for acute lymphoblastic leukemia: factor affecting relapse and survival. Blood 1989; 74: 862-871.
3. Horowitz MM, Messerer D, Hoelzer D et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991; 115: 13-18.
4. Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991; 78: 838-843.
5. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl J Med 1995; 332: 217-223.
6. Fefer A, Sullivan KM, Weiden P et al. Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. Prog Clin Biol Res 1987; 244: 401-408.
7. Gale RP, Horowitz MM, Ash RC et al. Identical-twin bone marrow transplants for leukemia. Ann Intern Med 1994; 120: 646-652.
8. Lee J-H, Lee K-H, Kim S et al. Relevance of protein C and S. antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 1998; 22: 883-888.
9. Lee K-H, Lee J-H, Choi S-J et al. Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 591-599.
10. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation. New Engl J Med 1975; 292: 895-902.
11. Sullivan KM. Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 1986; 4: 42-93.
12. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
13. Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729-1736.
14. Simpson DR, Nevill TJ, Shepherd JD et al. High incidence of extramedullary relapse of AML after busulfan/ cyclophosphamide conditioning and allogeneic stem cell transplantation. Bone Marrow Transplant 1998; 22: 259-264.
15. Blaise D, Maraninchi D, Archimbaud E et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-cytoxan versus cytoxan-tolal body irradiation as preparative regimen: a report from the Groupe d'Etudes de la Greffe de Moelle Osseuse. Blood 1992; 79: 2578-2582.
16. Ringdén O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723-2730.
17. Hassan M, Ljungman P, Bolme P et al. Busulfan bioavailability. Blood 1994; 84: 2144-2150.
18. Vassal G, Koscielny S, Challine D et al. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1996; 37: 247-253.
19. Colombini A, Barzaghi A, Castagneto M et al. Retro-orbital late relapse in a child with leukemia after allogeneic bone marrow transplantation. Acta Haematol 1995; 94: 44-47.
20. Lawson SE, Darbyshire PJ. Use of donor lymphocytes in extramedullary relapse of childhood acute lymphoblastic leukaemia following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 829-830.
21. Ueda S, Kanamori H, Sasaki S et al. Isolated extramedullary relapse in knee joint after allogeneic bone marrow transplantation for Ph ALL. Bone Marrow Transplant 1998; 21: 319-321.
22. Fleming DR, Greenwood MF, Garrison J et al. Lymphocyte infusion for delayed extramedullary relapse of acute leukemia following bone marrow transplantation. Leuk Lymphoma 1996; 21: 525-528.
23. Au WY, Lie AKW, Liang R, Kwong YL. Isolated extramedullary relapse of acute lymphoblastic leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1137-1140.
24. Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. New Engl J Med 1979; 300: 1068-1973.
25. Weiden PL, Sullivan KM, Flournoy N et al. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. New Engl J Med 1981; 304: 1529-1533.
26. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
27. Singhal S, Powles R, Kulkarni S et al. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse. Leuk Lymphoma 1999; 32: 505-512.
28. Zomas A, Stefanoudaki K, Fisfis M et al. Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytoma. Bone Marrow Transplant 1998; 21: 1163-1165.
29. Byrd JC, Edenfield WJ, Shields DJ et al. Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. J Clin Oncol 1995; 13: 1800-1816.